Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Clinical trial NCT02228213 · COMPLETED
Trial details
- NCT number
- NCT02228213
- Sponsor
- Innate Immunotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-05-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.